A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP of the European Pharmacopoeia monograph is often referred to as a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 Certificate of Suitability (COS). The purpose of a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 to their clients by showing that a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP has been issued for it. The manufacturer submits a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP holder for the record. Additionally, the data presented in the Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 DMF.
A Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Isoconazole nitrate, Travogen, Adestan G 100; Fazol; Gyno-Travogen; R 15454 suppliers with CEP (COS) on PharmaCompass.